(Total Views: 340)
Posted On: 02/10/2021 11:55:36 AM
Post# of 36566
Hey docj,
I found some more information. She seems accomplished in her field and it will be interesting to see how her role in NGIO will shape the future of the company. Perhaps a continuation of the AE37 Ii-key HER2 peptide vaccine?
https://talent4boards.com/generex-biotechnolo...directors/
I found some more information. She seems accomplished in her field and it will be interesting to see how her role in NGIO will shape the future of the company. Perhaps a continuation of the AE37 Ii-key HER2 peptide vaccine?
https://talent4boards.com/generex-biotechnolo...directors/
(0)
(0)
